At a Glance

Cipla is a leading global pharmaceutical company, dedicated to high-quality, branded and generic medicines. We are trusted by healthcare professionals and patients across geographies. Over the last 8 decades, we have strengthened our leadership in India’s pharmaceutical industry and fortified our promise of ‘Caring for Life’.

We are now strengthening our global focus by consolidating and deepening our presence in the key markets of India, South Africa, the US, and other economies of the emerging world

Incorporated

1935

Employees

23,000+

Turnover

USD 2.2 Billion

Founder (1898-1972)

Dr. K.A. Hamied

Chairman

Dr. Y.K. Hamied

Vice-Chairman

Mr. M.K. Hamied
 

Registered Office

Cipla Limited, Cipla House, Peninsula Business Park,
Ganpatrao Kadam Marg, Lower Parel, Mumbai 400 013

Listing

Equity Shares: BSE Limited and National Stock Exchange of India Limited
Global Depository Receipts: Luxembourg Stock Exchange

Highlights

  • Over 1500+ products across various therapeutic categories, with 50+ dosage forms.
  • Presence in over 80 countries

Approvals

Cipla’s state-of-the-art manufacturing facilities are cGMP compliant in conformity with national and international standards. Several dosage forms and APIs manufactured at these facilities continue to be approved by major international regulatory agencies including the US FDA, MHRA (UK), TGA (Australia), Federal Ministry of Health-Germany, MCC (South Africa), the Department of Health (Canada), INVIMA (Columbia) ANVISA (Brazil), the Danish Medical Agency, WHO and Ministry of Health of various countries.

Contact

Mumbai Central Office: +91 22 23082891, +91 22 23095521
Peninsula Business Park Office: +91 22 24826000, +91 22 24826701, +91 22 24826300